Abstract
Drug treatment of depression in patients with epilepsy faces problems, as most antidepressants have convulsive or pro-convulsive effects. Citalopram is a SSRI that has some pharmacological and kinetic properties that would theoretically recommend it in epileptic patients. We report the results of an ongoing study in 16 epileptic patients AEDs treated with mood disorders. Data cumulated so far indicate citalopram therapy does not deteriorate patient's seizure frequency, while leading to a relevant improvement of depressive rating.
| Translated title of the contribution | Citalopram in the treatment of depression in patients with epilepsy: Preliminary data |
|---|---|
| Original language | Italian |
| Pages (from-to) | 187-188 |
| Number of pages | 2 |
| Journal | Bollettino - Lega Italiana contro l'Epilessia |
| Issue number | 99 |
| Publication status | Published - 1997 |
ASJC Scopus subject areas
- Clinical Neurology
Fingerprint Dive into the research topics of 'Citalopram in the treatment of depression in patients with epilepsy: Preliminary data'. Together they form a unique fingerprint.
Cite this
Specchio, L. M., La Neve, A., Spinelli, A., Gneri, C., Galli, R., Tramacere, L., Specchio, N., Iudice, A., & Murri, L. (1997). Il trattamento antidepressivo con citalopram in pazienti con epilessia: Dati preliminari. Bollettino - Lega Italiana contro l'Epilessia, (99), 187-188.